Skip to main
LCTX
LCTX logo

LCTX Market Capitalization Overview

Market Cap: $185.09M as of Jun 13, 2025

$185.09M
Past Month+$77.65M (72.26%)
As of Jun 13, 2025, LCTX has a market capitalization of $185.09M. Over the past 30 days, its market cap has increased by 31.94%, while in the last 12 months, it has increased by 67.1%.

Market capitalization represents the total value of Lineage Cell Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

LCTX Market Cap Formula = Stock Price * Shares Outstanding

The market cap of LCTX helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

LCTX Market Cap History

DateMarket CapChange
Jun 2, 2025$151.86M+31.94%
May 1, 2025$115.10M+22.63%
Apr 1, 2025$93.86M-16.53%
Mar 3, 2025$112.44M-26.02%
Feb 3, 2025$151.98M+33.88%
Jan 2, 2025$113.52M+2.13%

LCTX End of Year Market Cap History

DateMarket CapChange
2025$185.09M+67.10%
2024$110.76M-41.93%
2023$190.74M-4.09%
2022$198.88M-51.84%
2021$412.97M+56.44%
2020$263.99M

FAQs About Lineage Cell Therapeutics Inc (LCTX) Market Cap

As of Jun 13, 2025, the market capitalization of LCTX is $185.09M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Lineage Cell Therapeutics Inc’s market capitalization has increased by 72.26%, changing from $107.45M to $185.09M as of Jun 13, 2025.

In the last 3 months, Lineage Cell Therapeutics Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Lineage Cell Therapeutics Inc’s market capitalization decreased from $190.74M in January to $110.76M in December, reflecting a -41.93% change.

In the past five years, LCTX has had a compound annual growth rate (CAGR) of -15.95% in market capitalization. This means its market cap has shrunk at an average rate of -15.95% per year.

Lineage Cell Therapeutics Inc (LCTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.